Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status

Small-cell lung cancer (SCLC) is highly sensitive to platinum-based chemotherapy. However, its indication in patients with a poor performance status (PS) at initial diagnosis is controversial. We retrospectively reviewed all clinical courses of pathologically diagnosed SCLC patients with poor PS, Ea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Case Rep Oncol
Egile Nagusiak: Aida, Yuka, Nakazawa, Kensuke, Shiozawa, Toshihiro, Ogawa, Ryoko, Kiwamoto, Takumi, Morishima, Yuko, Sakamoto, Toru, Sekine, Ikuo, Hizawa, Nobuyuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2019
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738152/
https://ncbi.nlm.nih.gov/pubmed/31543777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501548
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak